← Leaderboards
Yogendra H Raol
University Of Colorado Denver
$1,127,428
Attributed
$1,127,428
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $287.9K · FY2011–14$500K$375K$250K$125K$0
'11
'12
'13
'14
Funding mix
By agency
NIH$1,127,428 · 1
By mechanism
R01$1,127,428 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Kevin J. Staley$35,882,339
- Carol E Kaufman$6,971,721
- Michelle C Sarche$3,478,518
- Andrew M White$937,143
- Philip S Guzelian$2,477,034
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAcuteAffectAge GroupAdverse EffectsAnalogAnatomyAnimal ModelAntiepileptic AgentsAntioxidantsApoptoticAnalgesicsBehavioralBrainBrain Hypoxia-IschemiaBrain InjuriesCalciumCaspase-3Cell DeathCellsChildChronic Brain InjuryClinicClinical Treatment
Grant awards (4)
Efficacy of flupirtine for treatment of neonatal hypoxic-ischemic encephalopathy$281,354
R01 · FY2014 · HD · contact PI
Efficacy of flupirtine for treatment of neonatal hypoxic-ischemic encephalopathy$273,328
R01 · FY2013 · HD · contact PI
Efficacy of flupirtine for treatment of neonatal hypoxic-ischemic encephalopathy$287,882
R01 · FY2012 · HD · contact PI
Efficacy of flupirtine for treatment of neonatal hypoxic-ischemic encephalopathy$284,864
R01 · FY2011 · HD · contact PI